Skip to content
The Policy VaultThe Policy Vault

Cosopt PFCigna

reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP

Preferred products

  • generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution
  • generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution
  • generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution (generic Cosopt PF)

Initial criteria

  • Patient has tried one Step 1 Product (generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution [generic Combigan], generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution [generic Cosopt], or generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution [generic Cosopt PF])

Approval duration

1 year